Singapore Dealer Licence QMS: ISO 13485, MDSAP and GDPMDS
Updated: 2026-11-11 · GRZAN Regulatory Team · Verification date 2026-10-20
1. Key takeaways
A Singapore dealer’s licence requires evidence of a quality management system, and the applicant may choose between an ISO 13485 certificate, an MDSAP certificate and a GDPMDS certificate, with the important exception that a manufacturer’s licence does not accept GDPMDS. Three limits govern the choice: the ISO 13485 certificate must be issued by a certification body accredited by the Singapore Accreditation Council, the scope of the certificate must cover the relevant device categories and the activities carried out at the facility, and, under GN-02 R8 effective 1 April 2026, new applications and specified changes must be filed together with the audit report. Companies dealing only in Class A devices may file a declaration of conformity to a QMS instead of a certificate.
- Three QMS routes are available for importer and wholesaler licences: ISO 13485, MDSAP and GDPMDS. For a manufacturer’s licence, GDPMDS is not accepted.
- SAC accreditation of the issuing certification body is a threshold condition. A certificate from a body outside the SAC list does not support the application at all.
- Scope wording is checked against the activities applied for. A certificate limited to design and manufacture does not cover distribution.
- GN-02 R8, effective 1 April 2026, adds the audit report to the documentary set for new applications and specified changes.
- Companies handling Class A devices only may use the QMS declaration of conformity route, but the declaration is available solely on that basis.
2. Legal basis
Licensing of manufacturers, importers and wholesalers is governed by GN-02, Guidance on Licensing of Manufacturers, Importers and Wholesalers of MD. Revision R8 took effect on 1 April 2026, and its Annex 1 (export and re-export declaration) and Annex 5 (QMS declaration of conformity) are both dated April 2026. HSA’s own application page states the accreditation condition directly: the certificate needs to be issued by a certification body accredited by the Singapore Accreditation Council. The same page states that the QMS certificate should be submitted together with the audit report, which is the point R8 turned into an operative filing requirement rather than an expectation.
| Guidance | GN-02 R8, Guidance on Licensing of Manufacturers, Importers and Wholesalers of MD |
| Version and date | R8, effective 1 April 2026; Annex 1 (export and re-export declaration) and Annex 5 (QMS declaration of conformity) both April 2026 |
| Official requirement | HSA page Apply for a medical device dealer’s licence: the certificate needs to be issued by a certification body accredited by the Singapore Accreditation Council |
| Audit report | The QMS certificate, together with the audit report, should be submitted |
| Scope requirement | Certificate scope must include distribution of the relevant device categories and the activities carried out at the facility |
| Class A route | Declaration of Conformity to a QMS, available only to companies dealing solely in Class A devices |
The options are not uniform across licence types. The matrix below follows the HSA Quick Guide to Medical Device Product Registration and Dealer Licensing (go.gov.sg/quickguideapr2026) and the HSA dealer licensing application page.
| Licence type | ISO 13485 | MDSAP | GDPMDS | Export or re-export declaration | QMS declaration of conformity (Class A only) |
| Manufacturer licence | Accepted | Accepted | Not accepted | Not accepted | Accepted (Class A only) |
| Importer licence | Accepted | Accepted | Accepted | Accepted | Accepted (Class A only) |
| Wholesaler licence | Accepted | Accepted | Accepted | Accepted | Accepted (Class A only) |
The commercial reading of that matrix is straightforward: the licence type determines the documentary set before any question of preference arises. A company that both manufactures and distributes needs a certificate route that covers manufacturing, because GDPMDS cannot carry a manufacturer’s licence. Regulatory information in this article was verified to 26 October 2026 against secondary sources, namely GN-02 R8 with its annexes, the HSA dealer licensing application page and the HSA Quick Guide.
3. Expert insights
SAC accreditation is a hard gate, and it excludes a large number of certificates held by Chinese manufacturers. HSA requires the ISO 13485 certificate to be issued by a body accredited by the Singapore Accreditation Council. The most common problem we encounter is a client holding a valid ISO 13485 certificate from a domestic certification body that does not appear on the SAC list. The difficulty is not that the certificate is given reduced weight; it is that the licence application cannot be accepted on that basis. The issuing body should therefore be checked before the project is scheduled, not after the file is assembled.
GN-02 R8 introduced the audit report requirement, and it is a substantive 2026 change. R8, effective 1 April 2026, requires new applications and specified changes to be filed together with the audit report supporting the ISO 13485, MDSAP or GDPMDS certificate. Previously the certificate alone was sufficient. The documentary consequence is that a complete audit report has to be requested from the certification body in advance, and this is rarely a document the company already holds in its filing cabinet. Requests to certification bodies take time, so the report should be on the critical path from the first week.
GDPMDS is the cost-effective route for importers and wholesalers. GDPMDS, Good Distribution Practice for Medical Devices, is the Singapore standard SS 620, and it concentrates on the distribution chain rather than on design and manufacture. For a pure import or wholesale operation it fits the business better than a full ISO 13485 system and costs less to obtain and maintain. The limit is categorical: if the company also manufactures, it needs ISO 13485 or MDSAP, because GDPMDS cannot support a manufacturer’s licence.
The scope clause is the most frequently overlooked ground for rejection. HSA requires the certificate scope to include the device categories being dealt in and the activities carried out at the facility. A familiar situation is a certificate whose scope reads design and manufacture with no reference to distribution, followed by a deficiency notice on an importer licence application. We read the scope wording against the applied-for activity word by word before submission, because the mismatch is invisible to anyone who checks only that a valid certificate exists.
The value of MDSAP is one audit serving several markets. MDSAP covers the United States, Canada, Australia, Brazil and Japan. For a company building a position in those markets at the same time, an MDSAP certificate can replace several separate system audits. The Singapore requirement nevertheless applies unchanged: the audit report must be submitted, and the scope must cover the activities and device categories concerned. MDSAP shortens the audit burden; it does not shorten the documentary set.
4. Practical recommendations
- Check the SAC accredited body list at kick-off and confirm that the issuing body appears on it; if it does not, arrange re-certification before the application is planned.
- Request the complete audit report from the certification body early, since GN-02 R8 makes it a mandatory attachment.
- Verify that the certificate scope matches the licence type applied for, paying particular attention to whether distribution activities are covered.
- Assess GDPMDS for pure import or wholesale operations, where it fits the business more closely and costs less than a full system.
- Use the QMS declaration of conformity route where the company deals only in Class A devices, which avoids a certification investment that the licence does not require.
5. Verification checklist
- □ Issuing certification body confirmed on the SAC accredited list.
- □ Complete audit report obtained, as required by GN-02 R8.
- □ Certificate scope checked against the applied-for activities and device categories.
- □ QMS option confirmed against the licence type, noting that GDPMDS is not accepted for manufacturers.
- □ Class A declaration of conformity route evaluated where the company deals solely in Class A devices.
- □ Certificate within validity and covering the address declared in the application.
How GRZAN can help. GRZAN provides medical device and IVD registration, quality system, authorised representative and local testing support across Southeast Asia, including Singapore. Our team prepares dossiers to ASEAN CSDT structure, manages submissions and deficiency responses with HSA, and supports post-market vigilance obligations. Business enquiries: info@grzanglobal.com
Disclaimer
Prepared by GRZAN from publicly available regulation. It is provided for general information only and does not constitute legal advice. Legislation and official fees are subject to change by the competent authority.
About GRZAN
GRZAN (Global Regulatory Zone Access Navigator) — the global market-access navigator for medical devices and IVDs.
GRZAN is a specialist consultancy for medical device and IVD market access, providing end-to-end regulatory solutions across the product lifecycle and making international market entry simpler and faster.
Key figures. More than 25 wholly owned subsidiaries worldwide covering 50+ countries and regions; chosen by 100+ listed and leading Chinese device manufacturers, with 4,000+ successful cases; 12+ years in the sector and 200+ regulatory training sessions and seminars delivered.
What we do. Global market access: multi-country registration programmes, technical documentation, regulatory advice. Clinical evidence: clinical evaluation reports (CER), usability studies, overseas clinical investigations. Quality systems: ISO 13485, MDSAP, FDA QMSR and BGMP implementation and audit readiness. Authorised representative and licence-holder services across Southeast Asia, Latin America, the Middle East, Africa, Europe and North America.
Why GRZAN. A real operating entity, with the certificate held by the manufacturer: our direct overseas subsidiaries act as the compliant local holder, so the regulatory relationship stays clear and you keep control rather than being tied to a distributor. Direct access to the team: no time-zone gap, no language barrier, no cultural gap. Review points anticipated: we know what FDA 510(k), EU MDR, Southeast Asian, Latin American and Middle Eastern reviewers look for, which shortens timelines and reduces deficiency letters. Pathway planning: pre-decision analysis and risk assessment before you commit.
Every engagement rests on three commitments: efficiency through pre-submission review, certainty through a clear pathway, and stability through a licence-holder that stays in place.
Take your devices global with GRZAN
We work with manufacturers worldwide to open new markets with a clear regulatory pathway.
Contact us